Stocks fell in the afternoon session as markets reversed early gains, remaining cautious despite a softer inflation reading. A drop in the Producer Price Index suggested easing inflation, raising expectations for a potential Fed rate cut. Evolent Health’s volatile shares indicate the market considers recent news meaningful but not fundamentally changing. The stock is down 20.3% year-to-date, trading 70.5% below its 52-week high. With generative AI poised to impact large corporations, consider a semiconductor stock benefiting from the rise of AI. For more insights, access our free report on this growth story.

Read more at Barchart: ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know